JCRB0179 SNG-M
Cell information
Cell type:general cells (View Pricing Information)
JCRB No. | JCRB0179 | Cell Name | SNG-M |
---|---|---|---|
Profile | Intermedicately differentiated human adenocarcinoma cell line. | Other Name | |
Animal | human | Strain | |
Genus | Homo | Species | sapiens |
Sex | F | Age | 52 |
Identity | not done | Tissue for Primary Cancer | uterus |
Case history | uterus tumor | Metastasis | No |
Tissue Metastasized | Genetics | Mordal No. of chromosome is 40, Colony formation rate is 40%, Doubling time is 30 hours indicated by Nozawa,S. | |
Life Span | infinite | Crisis PDL | |
Morphology | epithelial-like | Character | intermediately differentiated adenocarcinoma |
Classify | tumor | Established by | Ishiwata,I. and Nozawa,S. |
Registered by | Nozawa,S. | Regulation for Distribution | |
Comment | The cells are responded to the progesterone. Mycoplasmas were decontaminated by MC210 in FDSC, 1990. | Year | 1990 |
Medium | Ham's F12 medium 80% with 20% fetal bovine serum. | Methods for Passages | Cells harvested after treatment with 0.25% trypsin. |
Cell Number on Passage | 2 x 10^5 cells/sq.cm. | Race | Japanese |
CO2 Conc. | 5 % | Tissue Sampling | metastatic lymph node |
Tissue Type |
Detection of virus genome fragment by Real-time PCR | |||||||||
---|---|---|---|---|---|---|---|---|---|
Detected DNA Virus | tested | Detected RNA Virus | tested | ||||||
CMV | - | parvoB19 | - | HCV | - | HTLV-1 | - | ||
EBV | - | HBV | - | HIV-1 | - | HTLV-2 | - | ||
HHV6 | - | HTLV-1 | - | HIV-2 | - | HAV | - | ||
HHV7 | - | HTLV-2 | - |
-/negative. +/positive. nt/not tested. (positive (+) does not immediately mean the production of infectious viral particles.) |
|||||
BKV | - | HIV-1 | - | ||||||
JCV | - | HIV-2 | - | ||||||
ADV | - | HPV18 | - | ||||||
Notes |
Reference | |
---|---|
Pubmed id:10545752 | Biological implications of growth factors on the mechanism of invasion in gynecological tumor cells. Ueda M,Ueki M,Terai Y,Ueki K,Kumagai K,Fujii H,Yoshizawa K,Nakajima M Gynecol Obstet Invest. 1999;48(3):221-8 |
Pubmed id:8641991 | Effects of sex steroids and growth factors on migration and invasion of endometrial adenocarcinoma SNG-M cells in vitro. Ueda M,Fujii H,Yoshizawa K,Abe F,Ueki M Jpn J Cancer Res. 1996 May;87(5):524-33 |
Pubmed id:7758945 | Trophinin and tastin, a novel cell adhesion molecule complex with potential involvement in embryo implantation. Fukuda MN,Sato T,Nakayama J,Klier G,Mikami M,Aoki D,Nozawa S Genes Dev. 1995 May 15;9(10):1199-210 |
Pubmed id:2787771 | Adoptive cellular immunotherapy to the endometrial carcinoma cell line xenografts in nude mice. Shimizu H,Inoue M,Tanizawa O Gynecol Oncol. 1989 Aug;34(2):195-9 |
Pubmed id:2746066 | [Glycosphingolipids in human uterine endometrium: expression of sulfoglycolipids and its fluctuation during menstrual cycle]. Kubushiro K Nihon Sanka Fujinka Gakkai Zasshi. 1989 Apr;41(4):397-404 |
Pubmed id:3027213 | [Reorganization of human ovarian adenocarcinoma cells and endometrial adenocarcinoma cells cultured in double-layered floating collagen gels]. Tsumura N,Kudo R,Sawada N Nihon Sanka Fujinka Gakkai Zasshi. 1986 Dec;38(12):2157-70 |
Pubmed id:3840512 | [Studies on the significance of PLD repair for radioresistance in human uterine adenocarcinoma cells]. Mitsunaga S Nihon Sanka Fujinka Gakkai Zasshi. 1985 Sep;37(9):1859-65 |
Pubmed id:2580923 | [Experimental studies on combination chemotherapy based on cell cycle analysis]. Tsuboi T Nihon Sanka Fujinka Gakkai Zasshi. 1985 Apr;37(4):629-36 |
Pubmed id:7276650 | [Studies on temperature sensitivity of human endometrial adenocarcinoma cells in vitro (author's transl)]. Udagawa Y Nihon Sanka Fujinka Gakkai Zasshi. 1981 Aug;33(8):1235-44 |
Pubmed id:642036 | Effects of progesterone on human endometrial carcinoma cells in vivo and in vitro. Ishiwata I,Udagawa Y,Okumura H,Nozawa S J Natl Cancer Inst. 1978 May;60(5):947-54 |
Pubmed id:858140 | Development and characterization of established cell lines from primary and metastatic regions of human endometrial adenocarcinoma. Ishiwata I,Nozawa S,Inoue T,Okumura H Cancer Res. 1977 Jun;37(6):1777-85 |
Images |
---|
Movies |
---|
LOT Information
Cell No. | JCRB0179 | Cell Name | SNG-M |
---|---|---|---|
LOT No. | 07212009 | Lot Specification | distribution |
Medium | Ham's F12 medium with 20% fetal bovine serum (GIBCO Cat. # 10099) | Temperature | 37 C |
Cell Density at Seeding | 7 - 20 x 10^4 cells/ml | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx 52 hrs | Cell Number in Vial (cells/1ml) | 4.2 x 10^6 |
Viability at cell freezing (%) | 67.7 | Antibiotics Used | free |
Passage Number | Unknown (16 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | Confirmed as human by NP, G6PD (type B), MD. |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - F12 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | Additional information |
Cell No. | JCRB0179 | Cell Name | SNG-M |
---|---|---|---|
LOT No. | 11152001 | Lot Specification | distribution |
Medium | Ham's F12 medium with 20% fetal bovine serum(Intergen RB52405). | Temperature | 37 C |
Cell Density at Seeding | 5.5 x 10^3 cells/sq.cm. | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. Medium change once a week and subculture once a week. |
Doubling Time | NT | Cell Number in Vial (cells/1ml) | 2.8 x 10^6 |
Viability at cell freezing (%) | 94.6 | Antibiotics Used | free |
Passage Number | P16* | PDL | NT |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | NT |
Chromosome Mode | NT | Chromosome Information | NT |
Surface Antigen | NT | DNA Profile (STR) | |
Adhesion | Yes | Exoteric Gene | NT |
Medium for Freezing | Culture medium containing 5% DMSO. | CO2 Conc. | 5 % |
Viability immediately after thawing (%) | Additional information |
Images |
---|
Cell No. | JCRB0179 | Cell Name | SNG-M |
---|---|---|---|
LOT No. | 10062017 | Lot Specification | distribution |
Medium | Ham's F12 medium with 20% fetal bovine serum (FBS; Sigma Cat. # 172012). | Temperature | 37 C |
Cell Density at Seeding | 2.3 - 5.8 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 31 hrs. | Cell Number in Vial (cells/1ml) | 3.2 x 10^6 |
Viability at cell freezing (%) | 78.6 | Antibiotics Used | free |
Passage Number | Unknown (16 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | ||
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - Ham's F12 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 78.6 | Additional information |
Cell No. | JCRB0179 | Cell Name | SNG-M |
---|---|---|---|
LOT No. | 11082022 | Lot Specification | distribution |
Medium | Ham's F-12 medium with 20% fetal bovine serum (FBS; GIBCO Cat. # 10437) | Temperature | 37 C |
Cell Density at Seeding | 2.3 - 6.0 x 10^4 cells/mL | Methods for Passages | Cells were harvested after treatment with 0.25% trypsin and 0.02% EDTA. |
Doubling Time | approx. 23 hrs. | Cell Number in Vial (cells/1ml) | 1.0 x 10^6 |
Viability at cell freezing (%) | 98 | Antibiotics Used | free |
Passage Number | Unknown (17 at bank) | PDL | |
Sterility: MYCOPLASMA | - | Sterility: BACTERIA | - |
Sterility: FUNGI | - | Isozyme Analysis | |
Chromosome Mode | Chromosome Information | ||
Surface Antigen | DNA Profile (STR) | D5S818:9,13 D13S317:8,10,11 D7S820:10,11,12 D16S539:10,12 VWA:16,17,18,20 TH01:6,7 AM:X TPOX:8,9 CSF1PO:11,12 |
|
Adhesion | Yes | Exoteric Gene | |
Medium for Freezing | 10% DMSO, 20% FBS - Ham's F-12 | CO2 Conc. | 5% |
Viability immediately after thawing (%) | 85 | Additional information |